SECOND AMENDMENT TO EXCLUSIVE CHANNEL COLLABORATION AGREEMENTChannel Collaboration Agreement • January 13th, 2014 • Intrexon Corp • Services-commercial physical & biological research
Contract Type FiledJanuary 13th, 2014 Company IndustryTHIS SECOND AMENDMENT is entered into as of this 10th day of January, 2014 and serves to amend the Exclusive Channel Collaboration Agreement entered into by and between Intrexon Corporation (“Intrexon”) and Fibrocell Science, Inc. (“Fibrocell”), on October 5, 2012 and first amended on June 28, 2013 (as amended, the “Agreement”). All capitalized terms not defined herein shall have the meaning set forth in the Agreement.
FIRST AMENDMENT TO EXCLUSIVE CHANNEL COLLABORATION AGREEMENTChannel Collaboration Agreement • July 9th, 2013 • Intrexon Corp • Services-commercial physical & biological research
Contract Type FiledJuly 9th, 2013 Company IndustryTHIS FIRST AMENDMENT is entered into as of this 28th day of June, 2013 and serves to amend the Exclusive Channel Collaboration Agreement entered into by and between Intrexon Corporation (“Intrexon”) and Fibrocell Science, Inc. (“Fibrocell”), on October 5, 2012 (the “Agreement”). All capitalized terms not defined herein shall have the meaning set forth in the Agreement.
FIRST AMENDMENT TO EXCLUSIVE CHANNEL COLLABORATION AGREEMENTChannel Collaboration Agreement • July 1st, 2013 • Fibrocell Science, Inc. • Pharmaceutical preparations
Contract Type FiledJuly 1st, 2013 Company IndustryTHIS FIRST AMENDMENT is entered into as of this 28th day of June, 2013 and serves to amend the Exclusive Channel Collaboration Agreement entered into by and between Intrexon Corporation (“Intrexon”) and Fibrocell Science, Inc. (“Fibrocell”), on October 5, 2012 (the “Agreement”). All capitalized terms not defined herein shall have the meaning set forth in the Agreement.